Feasibility and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) in children

Journal of Pediatric Gastroenterology and Nutrition

Volumn 54, Issue 5, 2012, Pages 594-600

  Di Giorgio, Angelo ^a   Agazzi, Roberto ^a   Alberti, Daniele ^a   Colledan, Michele ^a   D'Antiga, Lorenzo ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

children; liver transplantation; portal hypertension; transjugular intrahepatic portosystemic shunt

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; POLITEF;

ARTICLE; ASCITES; BLEEDING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER TRANSPLANTATION; LONG TERM CARE; MALE; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; SCHOOL CHILD; STENT; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

ADOLESCENT; ASCITES; CHILD; CHILD, PRESCHOOL; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER TRANSPLANTATION; MALE; PATIENT SELECTION; POLYTETRAFLUOROETHYLENE; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RETROSPECTIVE STUDIES;

EID: 84859975884     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182490c05     Document Type: Article

References (23)

1. de Franchis R, Baveno V faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53:762-8.
2. Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology 2010;51:306.
3. Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005;41:386-400. (Pubitemid 40165385)
4. Yang Z, Han G, Wu Q, et al. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene- covered stents versus bare stents: a meta-analysis. J Gastroenterol Hepatol 2010;25:1718-25.
5. Ling SC, Walters T, McKiernan PJ, et al. Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research. J Pediatr Gastroenterol Nutr 2011;52:254-61.
6. Shneider BL, Emre S, Groszman R, et al. Expert pediatric opinion on the report of the Baveno IV Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension. Pediatr Transplant 2006;10:893-907. (Pubitemid 44683633)
7. Lorenz JM. Placement of transjugular intrahepatic porto-systemic shunts in children. Tech Vasc Interv Radiol 2008;11:235-40.
8. Nagral A, Hasija RP, Marar S, et al. Budd-Chiari syndrome in children: experience with therapeutic radiological intervention. J Pediatr Gastroenterol Nutr 2010;50:74-8.
9. Huppert PE, Goffette P, Astfalk W, et al. Transjugular intrahepatic portosystemic shunts in children with biliary atresia. Cardiovasc Intervent Radiol 2002;25:484-93. (Pubitemid 36919587)
10. Heyman MB, LaBerge JM, Somberg KA, et al. Transjugular intrahepatic portosystemic shunts (TIPS) in children. J Pediatr 1997;131: 914-9. (Pubitemid 28027620)
11. Kelly DA, Davenport M. Current management of biliary atresia. Arch Dis Child 2007;92:1132-5. (Pubitemid 350221462)
12. Hackworth CA, Leef JA, Rosenblum JD, et al. Transjugular intrahepatic portosystemic shunt creation in children: initial clinical experience. Radiology 1998;206:109-14.
13. Van Ha TG, Funaki BS, Ehrhardt J, et al. Transjugular intrahepatic portosystemic shunt placement in liver transplant recipients: experiences with paediatric and adult patients. Am J Roentgenol 2005; 184:920-5. (Pubitemid 43899522)
14. Wróblewski T, Rowiński O, Zurakowski J, et al. Transjugular intrahepatic porto-caval shunt (TIPS) in treatment of portal hypertension in liver transplant recipients. Ann Transplant 2008;13:42-5.
15. Senzolo M, Tibbals J, Cholongitas E, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther 2006;23:767-75. (Pubitemid 43344596)
16. Masson S, Mardini HA, Rose JD, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience. QJM 2008;101:493-501. (Pubitemid 351791534)
17. Cookson DT, Zaman Z, Gordon-Smith J, et al. Management of transjugular intrahepatic portosystemic shunt (TIPS)-associated refractory hepatic encephalopathy by shunt reduction using the parallel technique: outcomes of a retrospective case series. Cardiovasc Intervent Radiol 2011;34:92-9.
18. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010;53: 397-417.
19. Riggio O, Ridola L, Angeloni S, et al. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial. J Hepatol 2010;53:267-72.
20. Tripathi D, Ferguson J, Barkell H, et al. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene- covered stents. Eur J Gastroenterol Hepatol 2006; 18:225-32.
21. Rössle M, Siegerstetter V, Euringer W, et al. The use of a polytetrafluoroethylene- covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): long-term follow-up of 100 patients. Acta Radiol 2006;47:660-6. (Pubitemid 44358955)
22. Mermuys K, Maleux G, Heye S, et al. Use of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation in children: initial clinical experience. Cardiovasc Intervent Radiol 2008;31(suppl 2):S192-6.
23. Cura M, Cura A, Suri R, et al. Causes of TIPS dysfunction. Am J Roentgenol 2008;191:1751-7.